Thyroid Nodule Worries: TIRAD 3 Insights for a 62-Year-Old

A 62-year-old man came to our iCliniq doctor concerned about thyroid nodules diagnosed six years ago. Initially, there was one nodule on the right side, but now there were multiple on both sides. They were described as 'small cystic nodules' and later as 'several small hypoechoic (an area on an ultrasound that is more solid than usual tissue) nodules’. Previous scans showed no concerning features, and he was told it was likely benign. Recent reports assigned a TIRAD 3 (thyroid imaging reporting and data system) rating, causing the patient concern about growth, benignity, signs of cancer, and the significance of TIRAD 3 in Indian endocrinology.

Our doctor reassured the patient that the growth of the nodules was not alarming. The shift in descriptions might not have indicated a change in nature, but more imaging would have been needed. A multinodular goiter that was suggestive of benign or adenomatous nodules indicated non-cancerous conditions. The absence of symptoms for six years had reduced the likelihood of cancer. TIRAD 3 had indicated a slight suspicion, but FNAC (fine needle aspiration cytology) had corresponded to a low four percent likelihood of cancer in TIRAD 3 nodules.

The patient expressed appreciation for the doctor's prompt and informative responses and mentioned that he had not experienced any discomfort over the past six years with the thyroid nodules. However, he remained concerned about the TIRAD 3 rating in the recent report and attached his scans for the doctor's review.

Our doctor analyzed the scan reports and reassured the patient that the thyroid nodules appeared benign, with no immediate concerns. The doctor suggested regular follow-up.

The patient responded with further concerns about the nature of the nodule, the need for follow-up with FNAC, adherence to TIRAD 3 guidelines, the possibility of developing cancer, and management.

Our doctor explained that most nodules likely contained fluid and could be confirmed as cystic with specific tests. 'Hypoechoic' was a term often used to describe them. Annual ultrasounds sufficed for follow-up, with additional scans if recent growth occurred. While a nodule's cancer risk could not be guaranteed, given the patient's history and age, it seemed rare. Treatment for thyroid nodules varied, based on factors like hormone levels or discomfort, and most did not need treatment unless problematic or suspicious for cancer.

The patient expressed gratitude for the doctor's prompt and thorough responses and appreciated our doctor for the precise and informative answers to all of his questions.